Directs Cannabis Regulatory Commission to adopt regulations concerning labeling, marketing, and sale of cannabidiol and products containing cannabidiol; prohibits sale of cannabidiol to minors.

This bill requires New Jersey's Cannabis Regulatory Commission to create rules for labeling, marketing, and sales of cannabidiol (CBD) products, including health standards, packaging details, and advertising limits. It prohibits selling CBD products to anyone under 21, with penalties of $250 for the first violation and up to $1,000 for repeat offenses. The rules must be based on scientific evidence and ban ads targeting minors or making unverified health claims. Exemptions include FDA-approved CBD products and medical cannabis under existing laws. These regulations apply to commercial CBD products but not to medical use or FDA-licensed items.